Citadel Advisors’s VSEE HEALTH INC WTS 29 VSEEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$944 Buy
25,500
+2,832
+12% +$162 ﹤0.01% 12839
2025
Q4
$1.81K Buy
+22,668
New +$2.41K ﹤0.01% 12481
2025
Q1
Sell
-17,330
Closed -$763 15790
2024
Q4
$763 Sell
17,330
-2,900
-14% -$154 ﹤0.01% 14273
2024
Q3
$829 Sell
20,230
-1,598
-7% -$173 ﹤0.01% 13949
2024
Q2
$4.37K Buy
+21,828
New +$3.29K ﹤0.01% 13493

Other funds holding VSEEW

Citadel Advisors's VSEEW Position: Q1 2026 in Review

Citadel Advisors increased its VSEE HEALTH INC WTS 29 (VSEEW) stake by 12% in Q1 2026, buying an estimated $162 and bringing the position to 25,500 shares worth $944. The position accounts for ﹤0.01% of the portfolio, ranked #12839.

Citadel Advisors first reported a position in VSEEW in Q2 2024 and has held it in 5 quarters since. The position peaked at $4.37K in Q2 2024. 19 funds tracked by Wall St. Rank hold VSEEW as of Q1 2026.

  • Citadel Advisors held 25,500 shares of VSEE HEALTH INC WTS 29 worth $944 as of Q1 2026.
  • Citadel Advisors bought 2,832 VSEE HEALTH INC WTS 29 shares in Q1 2026, an estimated $162.
  • VSEE HEALTH INC WTS 29 made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12839 holding.
  • Citadel Advisors first reported a position in VSEE HEALTH INC WTS 29 in Q2 2024 and has held it in 5 quarters since.
  • Citadel Advisors's VSEE HEALTH INC WTS 29 position peaked at $4.37K in Q2 2024.
  • 19 funds tracked by Wall St. Rank held VSEE HEALTH INC WTS 29 as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.